The role of endothelial cells in the immunopathogenesis of murine malaria-associated ALI/ARDS: effects and mechanisms
Description: Malaria is a major global health problem, especially in tropical and subtropical regions. In Brazil, 99% of the cases are concentrated in the Legal Amazon, where Plasmodium vivax are the major causes of disease and can be fatal. Plasmodium ssp. can lead to serious pulmonary condition complications with acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Respiratory complications are characterized by decreased capacity for gas exchange, increased leukocyte activity and inflammatory mediators in the lungs. A large number of potentially involved factors associated with significant difficulties in the study of disease in humans causes the molecular basis of lung dysfunction remains poorly understood, leading to high mortality in health facilities. Mechanisms related to innate immunity have been shown to be essential for the early control of Plasmodium infection through increased cytokines and activation of the cellular immune response. However, excessive and / or prolonged inflammatory response contributes to the pathogenesis and symptoms associated with severe malaria. Receptors Toll-like molecular patterns play a critical role in detecting pathogens and activation of innate immune response. Other important aspect that may be associated with the development of severe malaria is the ability of parasitized erythrocytes to be sequestered in the microvasculature of the tissue, activation of lung endothelial cells and increased pulmonary vascular permeability. This project aims to understand the role of some components of innate immunity in ALI/ARDS and the effect of adhesion of infected erythrocytes to endothelial cells, a study that will be addressed in a murine model of infection. Knowledge of aspects of the innate immune response will bring a significant contribution to the understanding of malaria associated ALI/ARDS, and enable studies aimed at developing new methodologies for the treatment of disease. (AU)
Funding type: grant
Funder scheme: Auxílio à Pesquisa - Regular
Start date: 2015-02-01
End date: 2017-01-31
Investigator: Sabrina Epiphanio (lead)
Institutions: Universidade de São Paulo, Universidade de São Paulo (USP). Faculdade de Ciências Farmacêuticas (FCF)
Topic: Malaria Research and Control
Field: Medicine
Domain: Health Sciences
Funded outputs count: 8
Funder award ID: 14/20451-0
OpenAlex ID: G2010555639
